One in five people with lung cancer has small-cell lung cancer. Previous research has shown that these tumor cells grow faster because they are fueled by a growth hormone called FGF-2. As a result the disease has a poor long-term survival rate because the tumors spread quickly.
A study published this week in the journal Cancer Research, examined a drug called PD173074 which blocks the receptor that FGF-2 uses to attach to tumor cells. When given to mice with the disease, the drug eliminated tumors in 50% of cases.
to read more about this study please go to Cancer Research
Please link to me :-)
You can use the code in the box below to link to me from your website
Related posts:
- Off-line IGRT for a non-small cell lung tumor using Elekta Synergy Non-Small Cell Cancer of the Lung courtesy of Elekta Adenocarcinoma...
- November is Lung Cancer Awareness Month Each year over 170,000 Americans develop lung cancer. Lung Cancer...
- Pfizer’s Sutent Drug Slows Pancreatic Cancer Pfizer Inc. announced final results from a randomized Phase 3...
Related posts brought to you by Yet Another Related Posts Plugin.
I like this site very much.
This is such a extraordinary site.
And it is not like other money bound place, the information here is really important.
I am definitely bookmarking it as well as sharing it with my friends.
Very extraordinary web.
The message here is really valuable.
I will share it with my friends.
Cheers
works for me
Very good concept, I like how you convey the msg.
Such a awesome site. I am saving this page.
I want to quote your post in my blog. It can?
And you et an account on Twitter?
Yes feel free to post on your blog.. we do have a twitter acct. its thefarbercenter. thank you for taking the time to post.
Thank you for the wonderful information.
cancer care resource website…
……